FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Related Tags >> Phase III   Novartis   Hepatitis C   FDA
Syndicate content

hepatitis B News

Most Popular hepatitis B Story

Metabasis stock tanks on double dose of bad news

Metabasis Therapeutics announced a pair of setbacks on Tuesday, saying that Schering-Plough is pulling out of a collaboration to develop a new therapy for hepatitis B and that an experimental... Read more...

Latest Headlines